L‐arginine as a potential GLP‐1‐mediated immunomodulator of Th17‐related cytokines in people with obesity and asthma

Obesity is considered as a risk factor for COVID‐19 with insulin resistance and increased production of inflammatory cytokines as likely mechanisms. Glucagon‐like peptide‐1 (GLP‐1) agonists and inhaled nitric oxide are proposed therapeutic approaches to treat COVID‐19 because of their broad anti‐inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Shu‐Yi, Linderholm, Angela, Showalter, Megan R., Chen, Ching‐Hsien, Fiehn, Oliver, Kenyon, Nicholas J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170586/
https://www.ncbi.nlm.nih.gov/pubmed/34123401
http://dx.doi.org/10.1002/osp4.500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170586/
https://www.ncbi.nlm.nih.gov/pubmed/34123401
http://dx.doi.org/10.1002/osp4.500

Ejemplares similares